MNJ Cancer Hospital Hyderabad Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00680940
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

MNJ Institute of Oncology & Regional cancer Center | MNJ Institute of Oncology, Regional Cancer Centre

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Head and Neck Neoplasms (Phase 3)

Lung Neoplasms (Phase 2)

Mucositis (Phase 3)

Stomatitis (Phase 3)

Uterine Cervical Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6